Anthropic Faces Lawsuit Over Misleading Claude Pricing
A new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
This piece highlights Which Dividend Fund Charges Least Fees and the factors to consider when evaluating expense structures.
23,749 articlesA new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...
Markets in early 2026 are pushing investors toward a core set of dividend stocks worth holding for life. The focus is...
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...
Southern Company is near Dividend Aristocrat territory after two decades of increases, yet a massive five-year capita...
A veteran trader explains why dividend-heavy healthcare equities remain a bedrock in 2026 markets, drawing on two dec...
Looking for a smart, long-term energy investment? This article breaks down one standout pick, why it fits a buy-and-h...
Retirees with $1.3 million are recalibrating portfolios for steady income as markets swing. This piece highlights thr...
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Investing often hinges on timing around earnings. This guide explains whether you should coca-cola stock before July ...
Income-focused investors are turning to monthly dividend ETFs yielding strong cash flow in 2026. Four funds stand out...